Regenics AS is a biotechnology company developing wound care products based on marine-derived materials. Its lead product, Collex®, is a 3D-printed wound dressing containing HTX™ derived from salmon roe and is being developed for the treatment of partial-thickness burns and chronic wounds. The company is also developing Vernex®, an HTX™-based hydrogel wound spray intended for the treatment of partial-thickness burns and chronic wounds.